regdanvimab: Clinical Trials

1 trial of regdanvimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
CT-P59, Placebo - SARS-CoV-2 Infection
Phase 2 / Phase 3CompletedCelltrion16422020-10-052022-07-20

Conditions studied

COVID-19 (1)

Sponsors

Celltrion (1)

Countries

South Korea (1)

Results publications

PMID 34473343, PMID 35295819, PMID 35713300, PMID 36043180